Your browser doesn't support javascript.
loading
Immunotherapy in locally advanced cervix cancer: A critical appraisal of the FDA indication based on ENGOT-CX11/GOG-3047/KEYNOTE-A18.
Monk, Bradley J; Tewari, Krishnansu S; Randall, Leslie M; Pothuri, Bhavana; Slomovitz, Brian M; Coleman, Robert L; Herzog, Thomas J.
Afiliação
  • Monk BJ; Florida Cancer Specialists and Research Institute, West Palm Beach, FL 33401, United States of America. Electronic address: bradley.monk@flcancer.com.
  • Tewari KS; Division of Gynecologic Oncology, University of California, Irvine, CA 92617, United States of America.
  • Randall LM; Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, United States of America.
  • Pothuri B; Division of Gynecologic Oncology, Perlmutter Cancer Center, NYU Langone Health, NYU Grossman School of Medicine, United States of America.
  • Slomovitz BM; Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, FL 33140, United States of America.
  • Coleman RL; Gynecologic Oncology, Texas Oncology, The Woodlands, TX 77380, United States of America.
  • Herzog TJ; Division of Gynecologic Oncology, University of Cincinnati, Cincinnati, OH 45220, United States of America.
Gynecol Oncol ; 188: 81-82, 2024 Jun 26.
Article em En | MEDLINE | ID: mdl-38936284

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Gynecol Oncol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Gynecol Oncol Ano de publicação: 2024 Tipo de documento: Article